This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Binder, G. Articles by Eggermann, T. Search for Related Content PubMed PubMed Citation Articles by Binder, G. Articles by Eggermann, T. Related Collections Pediatric Endocrinology

IGF-II Serum Levels Are Normal in Children with Silver-Russell Syndrome Who Frequently Carry Epimutations at the IGF2 Locus

University Children’s Hospital, 72076 Tübingen, Germany; and Institute of Human Genetics, University Hospital, Rheinisch-Westfälische Technische Hochschule Aachen, 52074 Aachen, Germany

Address all correspondence and requests for reprints to: PD Dr. Gerhard Binder, Pediatric Endocrinology Section, University-Children’s Hospital, Hoppe-Seyler-Strasse1, 72076 Tübingen, Germany. E-mail: gerhard.binder{at}med.uni-tuebingen.de.

Context: Epigenetic mutations of 11p15 encompassing IGF2 are present in short children with Silver-Russell syndrome (SRS) with high frequency (31–50%). It has been speculated that these mutations characterized by demethylation of ICR1 cause diminished IGF2 expression.

Objective: We aimed to determine the prevalence of pathologically low IGF-II serum levels in children with SRS.

Subjects: SRS was defined by birth weight or length below the 3rd percentile, lack of postnatal catch-up growth, and the presence of two of the following characteristics: typical face, relative macrocephaly, and skeletal asymmetry. Serum samples of 30 patients were available. Mean age was 5.4 ± 2.1 yr.

Methods: The serum levels of IGF-I, IGF-II, IGF binding protein (IGFBP)-2, and IGFBP-3 were measured by RIA and compared with age-related reference values and with serum concentrations measured in age- and gender-matched controls born small for gestational age (SGA), but lacking major dysmorphic features. Analysis of genomic DNA was possible in a subgroup of children with SRS: the methylation status of the ICR1 locus on 11p15 and the parental origin of chromosome 7 were analyzed in 9 and 23 children, respectively.

Results: Demethylation of ICR1 was found in 44% and uniparental disomy in 17% of the tested children with SRS. The median IGF-II serum level in SRS was 441 µg/liter (range, 238–875). This was significantly higher than in the SGA controls: 387 µg/liter (range, 265–596) (P < 0.03), but below the median value of the age-related reference, which was 532 µg/liter. The four children with SRS and ICR1 demethylation had high-normal and normal IGF-II serum levels that were higher than the levels of their SGA controls. IGF-I, IGFBP-2, and IGFBP-3 serum levels were not different between the SRS children and their SGA controls.

Conclusions: Our data render it unlikely that demethylation of ICR1 on 11p15 does cause diminished IGF-II serum levels in children with SRS. This observation does not exclude deficient IGF-II action before birth.

This article has been cited by other articles:

				D Bartholdi, M Krajewska-Walasek, K Ounap, H Gaspar, K H Chrzanowska, H Ilyana, H Kayserili, I W Lurie, A Schinzel, and A Baumer Epigenetic mutations of the imprinted IGF2-H19 domain in Silver-Russell syndrome (SRS): results from a large cohort of patients with SRS and SRS-like phenotypes J. Med. Genet., March 1, 2009; 46(3): 192 - 197. [Abstract] [Full Text] [PDF]

				S. Bruce, K. Hannula-Jouppi, J. Peltonen, J. Kere, and M. Lipsanen-Nyman Clinically Distinct Epigenetic Subgroups in Silver-Russell Syndrome: The Degree of H19 Hypomethylation Associates with Phenotype Severity and Genital and Skeletal Anomalies J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 579 - 587. [Abstract] [Full Text] [PDF]

				R. Murphy, J. Baptista, J. Holly, A. M. Umpleby, S. Ellard, L. W. Harries, J. Crolla, T. Cundy, and A. T. Hattersley Severe Intrauterine Growth Retardation and Atypical Diabetes Associated with a Translocation Breakpoint Disrupting Regulation of the Insulin-Like Growth Factor 2 Gene J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4373 - 4380. [Abstract] [Full Text] [PDF]

				G. Binder, A.-K. Seidel, D. D. Martin, R. Schweizer, C. P. Schwarze, H. A. Wollmann, T. Eggermann, and M. B. Ranke The Endocrine Phenotype in Silver-Russell Syndrome Is Defined by the Underlying Epigenetic Alteration J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1402 - 1407. [Abstract] [Full Text] [PDF]

				S Abu-Amero, D Monk, J Frost, M Preece, P Stanier, and G E Moore The genetic aetiology of Silver-Russell syndrome J. Med. Genet., April 1, 2008; 45(4): 193 - 199. [Abstract] [Full Text] [PDF]

				I. Netchine, S. Rossignol, M.-N. Dufourg, S. Azzi, A. Rousseau, L. Perin, M. Houang, V. Steunou, B. Esteva, N. Thibaud, et al. 11p15 Imprinting Center Region 1 Loss of Methylation Is a Common and Specific Cause of Typical Russell-Silver Syndrome: Clinical Scoring System and Epigenetic-Phenotypic Correlations J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3148 - 3154. [Abstract] [Full Text] [PDF]